Organigram Holdings Inc. (OTCQX: OGRMF) announced on April 26th that the company has applied to up-list its common shares onto the NASDAQ Global Select Market (NASDAQ).
The company has already decided to file a Form 40-F Registration Statement with the United States Securities Exchange Commission (SEC) in preparation for the NASDAQ listing.
The listing of Organigram common shares onto the NASDAQ Global Select Market is still subject to approval by the NASDAQ and the completion of specific listing and regulatory agency requirements. Organigram common shares under the TSX Venture Exchange will continue to trade under the stock ticker symbol of “OGI”.
Paolo De Luca, Chief Financial Officer of Organigram, stated: “As a management team we are seeing increased interest from investors in the U.S. and internationally and believe that having a listing on the NASDAQ will facilitate trading. In addition, based on precedents in the cannabis space, we expect trading volumes to increase which should result in increased liquidity for all investors”.
Curious about how you can make money investing in cannabis? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.